Coverage
-
September 07, 2023
Walgreens has agreed to pay $44 million to resolve a certified consumer class action alleging the pharmacy chain should have known now-defunct Theranos' finger-prick blood tests were faulty when it helped market them, according to documents filed in Arizona federal court Wednesday.
10 other articles on this case.
View all »